- Art
- 25
- Verfahren
- neg-wo-call
- Referenznummer
- 651170-2025
- CPV
- 33000000
Justification for Direct Award – Equipment for Gradient Separation of Pancreatic Tissue This procurement concerns the acquisition of new equipment for gradient separation of islet cells from pancreatic tissue at the Sect…
ion for Cell Therapy (SfC), Oslo University Hospital (OUS). The contracting authority intends to procure two (2) units of Cellsaver Xtra from LivaNova AS. The estimated annual usage is 15 procedures. Please refer to the attached detailed justification. In light of the technical requirements, the nee
d for methodological validation, and regulatory considerations, LivaNova AS is assessed to be the only supplier capable of fulfilling the requirements. The conditions for applying the negotiated procedure without prior publication, pursuant